Fundraising FoxCardialen Inc
St. Louis, US · Delaware corporation · 3 known investors
Find your way into Cardialen Inc
Sign up to see every warm intro you have to Cardialen Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardialen Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developing implantable low-energy pain-free atrial cardioverters for atrial fibrillation.
Founders & leadership
MB
M. Brent SheltonExecutive
PS
Paula SkjefteExecutive
NL
Nick LannersExecutive
IE
Igor EfimovNamed on SEC filing
Board
EA
Eric A. GulveBoard director
WW
Warren WatsonBoard director
WS
William SchmidtBoard director
RJ
Robert J. CalcaterraBoard director
BB
Brian BuetnerBoard director
Investors · 3
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · Not right? Tell us
RiverVest Venture Partnerslisted by RiverVest Venture PartnersSt. Louis · $500K – $3Mvia Jay W. Schmelter · board
How we know: RiverVest Venture Partners's portfolio page · board seat on SEC Form D · Not right? Tell us
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$25.5M disclosed across 5 rounds · 2013–2021
▶$4.4MraisedJul 2021 · 18 investors · Other Health CareRule 506(b)
▶$4.4MraisedJul 2021 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jay SchmelterDirector
- William SchmidtDirector
- Anna FrenchDirector
- Warren WatsonDirector
- Jeff PetersExecutive Officer, Director
- Thomas ThalerDirector
- Offering amount
- $4.4M
- Amount sold
- $4.4M
- Minimum investment
- $967
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$16.1MraisedAug 2018 · 16 investors · Other Health CareRule 506(b)
▶$16.1MraisedAug 2018 · 16 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Igor EfimovDirector
- Jeff PetersExecutive Officer, Director
- William SchmidtDirector
- Warren WatsonDirector
- Robert CalcaterraDirector
- Brian BeutnerDirector
- Eric GulveDirector
- Offering amount
- $16.1M
- Amount sold
- $16.1M
- Minimum investment
- $8.2K
- First sale
- Jul 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$889.9KraisedAug 2018 · 13 investors · Other Health CareRule 506(b)
▶$889.9KraisedAug 2018 · 13 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- William SchmidtDirector
- Brian BeutnerDirector
- Eric GulveDirector
- Warren WatsonDirector
- Jeff PetersExecutive Officer, Director
- Robert CalcaterraDirector
- Igor EfimovDirector
- Offering amount
- $1M
- Amount sold
- $889.9K
- Minimum investment
- $5K
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedJun 2015 · 22 investors · Other Health CareRule 506(b)
▶$1.6MraisedJun 2015 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Warren WatsonDirector
- William SchmidtDirector
- Robert J. CalcaterraDirector
- Brian BuetnerDirector
- M. Brent SheltonExecutive Officer
- Paula SkjefteExecutive Officer, Director
- Eric A. GulveExecutive Officer, Director
- Igor EfimovDirector
- Offering amount
- $2M
- Amount sold
- $1.6M
- Minimum investment
- $10K
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedJan 2014 · 18 investors · Other Health CareRule 506(b)
▶$2.5MraisedJan 2014 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Robert J. CalcaterraDirector
- Eric A. GulveExecutive Officer, Director
- Warren WatsonDirector
- Nick LannersExecutive Officer
- Igor R. EfimovDirector
- Brian BuetnerDirector
- M. Brent SheltonExecutive Officer
- Paula SkjefteExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $2.5M
- Minimum investment
- $1
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $2.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $2M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $250.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $216K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Cardialen Inc do?
- Developing implantable low-energy pain-free atrial cardioverters for atrial fibrillation.
- Who are Cardialen Inc's investors?
- Cardialen Inc's investors include Broadview Ventures, RiverVest Venture Partners, Cultivation Capital.
- How much funding has Cardialen Inc raised?
- Cardialen Inc has disclosed $25.5M raised across 5 rounds.
- Where is Cardialen Inc headquartered?
- Cardialen Inc is headquartered in St. Louis, US.